CATALANOTTI, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 1.360
EU - Europa 1.026
AS - Asia 293
AF - Africa 44
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.727
Nazione #
US - Stati Uniti d'America 1.332
IT - Italia 527
CN - Cina 192
UA - Ucraina 146
FI - Finlandia 66
SE - Svezia 63
NL - Olanda 61
IE - Irlanda 50
VN - Vietnam 50
CI - Costa d'Avorio 43
DE - Germania 43
CA - Canada 28
GB - Regno Unito 26
FR - Francia 16
CZ - Repubblica Ceca 13
IN - India 13
HK - Hong Kong 12
ES - Italia 8
TR - Turchia 8
IR - Iran 7
SG - Singapore 5
CH - Svizzera 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RU - Federazione Russa 2
AR - Argentina 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
IL - Israele 1
KR - Corea 1
KZ - Kazakistan 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 2.727
Città #
Chandler 320
Jacksonville 117
Naples 96
Ashburn 79
Millbury 68
Beijing 64
Napoli 64
Princeton 63
Boston 60
Amsterdam 52
Vietri Sul Mare 49
Dong Ket 48
Nanjing 47
Dearborn 26
Ottawa 25
Des Moines 22
Shenyang 20
Wilmington 19
Lawrence 18
Milan 18
Nanchang 17
Woodbridge 15
Hebei 14
Formia 13
Cercola 12
Hong Kong 11
Kronberg 11
Ann Arbor 10
Norwalk 10
Boardman 9
Langhirano 8
Falls Church 7
Lund 7
Lappeenranta 5
Los Angeles 5
Orta di Atella 5
Sant'Antonio Abate 5
Seattle 5
Tianjin 5
Torre del Greco 5
Washington 5
Changsha 4
Dublin 4
Indiana 4
Jiaxing 4
Lucca 4
Mountain View 4
Redwood City 4
Rome 4
Salerno 4
Angri 3
Battipaglia 3
Bologna 3
Cagliari 3
Coimbatore 3
Guangzhou 3
Hefei 3
Hyderabad 3
Merate 3
Platania 3
Pune 3
San Mateo 3
Sant'anastasia 3
Santa Monica 3
Toronto 3
Venta De Baños 3
Adeje 2
Adelfia 2
Andover 2
Auckland 2
Boscoreale 2
Caserta 2
Fairfield 2
Florence 2
Fremont 2
Giugliano In Campania 2
Helsinki 2
Ho Chi Minh City 2
Letovice 2
Minori 2
Molfetta 2
Orange 2
Paris 2
Parma 2
Perugia 2
Piacenza 2
Pozzuoli 2
Přerov 2
Reggio Calabria 2
San Francisco 2
Sant'antimo 2
Thiene 2
Turin 2
Villeurbanne 2
Visone 2
Athens 1
Aversa 1
Barcelona 1
Bari 1
Barletta 1
Totale 1.606
Nome #
3D GRID-based pharmacophore and Metadynamics approaches for the rational design of N-Methyl β-sheet breaker peptides as inhibitors of the Alzheimer's Aβ-amyloid fibrillogenesis 103
Ubiquitylation of BBSome is required for ciliary assembly and signaling 71
Inibizione selettiva dei sistemi di trasporto neuronale Na+ dipendente dell’acido glutammico (EAAT). Progettazione e sintesi di nuovi potenziali agenti neuroprotettivi. 71
cADRP Analogues as Probes for the Cellular Ca2+ Signaling 62
Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors 59
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 58
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity 57
Understanding the Aβ(1–42) Fibrillogenesis Inhibition of Novel N-Methyl Beta-sheet Breaker Peptides by Molecular Dynamics Simulations 55
Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR. 55
cADPR Analagues as Probes for the Cellular Ca2+ Ions Signaling 54
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 52
Benzoxepin-Derived Estrogen Receptor Modulators: A Novel Molecular Scaffold for the Estrogen Receptor 52
Taxol: a Great Peptido Mimetic Produced byNature 51
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 51
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 49
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. 48
Novel propanamides as fatty acid amide hydrolase inhibitors 48
2'-Deoxy-8-(propyn-1-yl)adenosine-containing oligonucleotides: effects on stability of duplex and quadruplex structures 46
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 45
SAR studies for drug-discovery: cADPR analogues for the regulation of Ca2+ concentration in PC12 neuronal cells. 43
Syntheses of [1-15N]-2'-deoxyinosine, [4-15N]-2'-deoxyAICAR, and [1-15N]-2'-deoxyguanosine. 42
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target. 41
A multidisciplinary approach to study the carboxyl-terminal portion of the excitatory amino acid transporter EAAT2:implications for the design of new neuroprotective agents. 40
Synthesis and Biological Evaluation of a New Structural Simplified Analogue of cADPR, a Calcium-Mobilizing Secondary Messenger Firstly Isolated from Sea Urchin Eggs 39
Novel Atypical Antipsychotic Agents: Rational Design, an Efficient Palladium-Catalyzed Route, and Pharmacological Studies 37
Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode 37
Synthesis of 5-methylamino-2'-deoxyuridine derivatives. 36
Non-nucleooside HIV-1 reverse transcriptase (RT) inhibitors : Past, present. And future perspectives. 36
Circular dichroism and termal melting differentiation of Hoechst 33258 bindings to the curved (A4T4) and non curved (T4A4) DNA sequences. 36
Assignment of the relative stereochemistry of 13,19-didesmethylspirolide C, a macrocyclic toxin isolated from Adriatic dinoflagellate Alexandrium ostenfeldii, by NMR and molecular modelling-based techniques 36
Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system 36
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore. 35
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 34
The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation 34
From protein-protein interaction to E2 inhibitors leads: identification of peptide binding of UbcH10 33
A multidisciplinary approach for the investigation of the antimalarial activity of natural endoperoxides 33
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW FAAH INHIBITORS 33
Endoperoxide Derivatives from Marine Organisms: 1,2-Dioxanes of the Plakortin Family as Novel Antimalarial Agents. 32
A multidisciplinary approach for the investigation of the antimalarial activity of natural endoperoxides 32
Development of novel and potent atypical antipsychotic agents: from rational design to drug candidates 32
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors 31
Full relative stereochemistry assignment and conformational analysis of 13,19-didesmethyl spirolide C via NMR- and Molecular Modeling-based techniques. A step towards the comprehension of spirolide mechanism of action. 30
Development of potent and selective peripheral 5-HT3 receptor agonists and antagonists, keystones of a new therapeutic strategy to cardiac diseases 30
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 30
Discovery of Huperzine A-Tacrine Hybrids as Potent Inhibitors of Human Cholinesterases Targeting Their Midgorge Recognition Sites 29
Pyrrolo[1,3]benzothiazepine-Based Atypical Antipsychotic Agents. Synthesis, Structure-Activity Relationship, Molecular Modeling, and Biological Studies 29
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 29
A Rational Approach to the Design of Selective Substrates and Potent Nontransportable Inhibitors of the Excitatory Amino Acid Transporter EAAC1 (EAAT3). New Glutamate and Aspartate Analogues as Potential Neuroprotective Agents 28
Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2 28
Theoretical and experimental structural studies on the carboxyl-terminal portion of the excitatory amino acid transporter EAAT2. Implications for the design of new neuroprotective agents 27
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin 27
Target Protector PNA: a new tool in Cystic Fibrosis treatment 27
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen 27
Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3 Receptor Ligands: Inhibition of Cocaine-Seeking Behaviour and the Role of Dopamine D3/D2Receptors. 25
Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors. 25
Insight into the mechanism of the antimalarial action of plakortins, simple 1,2-dioxane antimalarials 25
“NORTHERN” RIBOSE AND PYROPHOSPHATE MODIFIED cADPR ANALOGUES: A NOVEL CLASS OF POTENTIAL Ca2+ MOBILIZERS 25
Combined FAAH and COX inhibition by Flurbiprofen amide derivatives for the treatment of pain and inflammation 25
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 24
Substrates inhibitors and blockers of excitatory amino acid transporters for the treatment of neurodegeneration: critical considerations. 24
Derivati 1,2-diossanici di origine marina ad attività antimalarica 24
Derivati 1,2-diossanici di origine marina ad attività antimalarica 23
Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2. 23
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. 22
Synthetic polynucleotides and analogues as models for studies concerning DNA. 22
Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases. 21
Full relative stereochemistry assignment and conformational analysis of 13,19-didesmethyl spirolide C via NMR- and molecular modeling-based techniques. A step towards understanding spirolide's mechanism of action. 21
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 21
Sviluppo di nuovi antipsicotici atipici a struttura Pirrolobenzotiazepinica 19
Design and pharmacological evaluation of Ibuprofen amides derivatives as dual FAAH/COX inhibitors 19
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders 18
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors. 18
Oligonucleotidi contenenti 2’-deossi-8-(1—propinil)-Adenosina: stabilità delle strutture quadruplex. 18
Exploiting protein fluctuation at human cholinesterase active-sites. New Perspectives 18
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 18
Sintesi di molecole attive nel trattamento del Cocaine-Craving 17
Exploiting extra-interaction sites in the mid-gorge and peripheral site of cholinesterase: rational design of novel, selective, and highly potent inhibitors 17
NADD: Nature Aided Drug Discovery 15
Sintesi di oligonucleotidi modificati per studi chimico-fisici e biologici. 15
Investigation of a novel pharmacophore for the development ofinnovative antimalarial agents. 14
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 13
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 13
Nuovi analoghi omo- ed eterodimerici della Tacrina quali potenti e selettivi inibitori dellAcetilcolinoesterasi e della Butirrilcolinestersi 13
Hijacking SARS-Cov-2/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on receptor binding region 12
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury 12
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 12
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 12
Oligonucleotides Containing an Acridine Group Covalently Bonded to the Nucleotide Flanking the 3′-3′ Phosphodiester Junction for Alternate Strand Triple Helix Formation 11
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 8
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 5
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 3
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 3
null 3
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 2
Totale 2.894
Categoria #
all - tutte 10.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 5 5
2019/2020346 116 3 27 8 31 15 25 4 5 42 37 33
2020/2021443 3 27 38 29 55 58 31 21 35 8 84 54
2021/2022502 10 1 3 5 2 15 7 25 70 55 114 195
2022/2023736 97 58 24 71 86 86 13 68 111 56 55 11
2023/2024439 44 73 63 35 25 40 35 78 16 29 1 0
Totale 2.894